Stay updated on Pembrolizumab & Cetuximab in HNSCC Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab & Cetuximab in HNSCC Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab & Cetuximab in HNSCC Clinical Trial page

  1. Check
    6 days ago
    No Change Detected
  2. Check
    13 days ago
    Change Detected
    Summary
    The study record for pembrolizumab combined with cetuximab is available, with details on the trial design, eligibility, locations, outcomes, and completed study status. Results, record history, and a study protocol document are also present.
    Difference
    73%
    Check dated 2026-11-08T15:16:29.000Z thumbnail image
  3. Check
    20 days ago
    Change Detected
    Summary
    The ClinicalTrials.gov page still displays a 403 Forbidden error instead of the study record. Its footer revision changed from v3.7.2 to v3.8.0.
    Difference
    0.2%
    Check dated 2026-11-01T16:18:44.000Z thumbnail image
  4. Check
    27 days ago
    Change Detected
    Summary
    A notice appears above the page explaining that NIH is transitioning from the term “Artificial Intelligence” to “Super Intelligence” and linking to updates and FAQs.
    Difference
    1%
    Check dated 2026-10-25T15:32:33.000Z thumbnail image
  5. Check
    34 days ago
    Change Detected
    Summary
    The site footer’s revision identifier changed from v3.7.1 to v3.7.2, while the page continues to display a 403 error.
    Difference
    0.2%
    Check dated 2026-10-18T16:11:51.000Z thumbnail image
  6. Check
    41 days ago
    Change Detected
    Summary
    The footer’s ClinicalTrials.gov revision identifier changed from v3.7.0 to v3.7.1.
    Difference
    0.2%
    Check dated 2026-10-11T16:19:42.000Z thumbnail image
  7. Check
    62 days ago
    Change Detected
    Summary
    The Study record page now displays a 403 error instead of the detailed study content, with a minimal header/footer and an error message.
    Difference
    21%
    Check dated 2026-09-20T19:49:42.000Z thumbnail image

Stay in the know with updates to Pembrolizumab & Cetuximab in HNSCC Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab & Cetuximab in HNSCC Clinical Trial page.